Navigation Links
Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer
Date:9/10/2007

elease which are not purely historical, including statements regarding Peregrine Pharmaceuticals' intentions, hopes, beliefs, expectations, representations, projections, plans or predictions of the future are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The forward-looking statements involve risks and uncertainties including, but not limited to, the risk that the protocol will not be approved, the risk that the company will experience delays or difficulties in enrolling patients in the study, and the risk that the results from this trial will not be consistent with the results of prior trials or pre-clinical studies. It is important to note that the company's actual results could differ materially from those in any such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, uncertainties associated with completing preclinical and clinical trials for our technologies; the early stage of product development; the significant costs to develop our products as all of our products are currently in development, preclinical studies or clinical trials; obtaining additional financing to support our operations and the development of our products; obtaining regulatory approval for our technologies; anticipated timing of regulatory filings and the potential success in gaining regulatory approval and complying with governmental regulations applicable to our business. Our business could be affected by a number of other factors, including the risk factors listed from time to time in the company's SEC reports including, but not limited to, the annual report on Form 10-K for the year ended April 30, 2007 and the annual report on Form 10-K for the year ended April 30, 2007. The company cautions investors not to place undue reliance on the forward-looking statements contained in this press release. Peregrine Pharmaceuticals, Inc. disclaims any obligation, and does
'/>"/>
SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Peregrine Pharmaceuticals Reports Positive Top-Line Results in Bavituximab Combination Therapy Trial in Advanced Cancer Patients
2. Positive Results Using Affitech-Identified Human Antibody That Blocks VEGF Binding to VEGF Receptor 2 in Preclinical Cancer Model Reported by Peregrine
3. Peregrine Pharmaceuticals Highlights Significant Advances in the Companys Clinical and Preclinical Cancer Programs Presented This Week at the AACR Annual Meeting
4. Data Presented at AACR Meeting Shows Peregrines Immunocytokine Fusion Proteins Reduce Growth of B-Cell Lymphoma Tumors by 85% in Preclinical Studies
5. Data Presented at AACR Meeting Show Peregrines Bavituximab Equivalent Can Generate Curative Immune Responses as Part of a Vaccine-Like Regimen in Preclinical Models of Aggressive Brain Cancer
6. Data Presented at AACR Meeting Shows Peregrines Selective Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical Cancer Models
7. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
8. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... HILL, N.C. , Sept. 19, 2014 /PRNewswire/ ... role in forging relationships with key opinion leaders ... market and competition. Despite the critical nature of ... created many challenges, including altering the landscape for ... According to research, the oversight responsibility ...
(Date:9/19/2014)... Harwood Feffer LLP ( www.hfesq.com ) is ... PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: ... its fiduciary duties to shareholders or violated the federal ... Company disclosed: "On September 11, 2014, [PDL] was orally ... Young LLP ("EY"), that it was resigning effective September ...
(Date:9/19/2014)... , Sept. 19, 2014 A pharmaceutical ... Practices, LLC with three issues he wanted the research ... use of external personnel (especially for secondary research) to ... the face of increased workload , Automation of ... knowledge management , How to implement and manage ...
Breaking Medicine Technology:Role of Medical Science Liaisons Shifting in Healthcare Industry 2Harwood Feffer LLP Announces Investigation of PDL BioPharma, Inc. 2In Era of Competing Needs, Market Research Groups Under Pressure to Utilize Automation and External Staffing 2
... A new study by researchers from Children,s Mercy ... that rapid electronic review of children,s heart images by ... and treatment of potentially serious pediatric heart problems. The ... National Conference and Exhibition in San Francisco. ...
... LAKES, N.J., Oct. 4 Medco Health Solutions, ... announce its third-quarter 2010 financial results in a ... November 2, 2010.   (Logo: http://photos.prnewswire.com/prnh/20100609/MEDCOLOGO) ... release, management will hold a conference call at ...
Cached Medicine Technology:New Study Shows Telemedicine Works to Effectively Identify Heart Problems in Children Far from a Specialized Medical Center 2Medco Announces Date for Third-Quarter 2010 Financial Results 2
(Date:9/19/2014)... “Copay coupons,” a drug manufacturer marketing tactic ... patients with prescription drug coverage, may now be infiltrating ... from the Department of Health and Human Services ... prohibit suppliers from offering side-payments to increase sales of ... The report highlights that two recent surveys, including one ...
(Date:9/19/2014)... (PRWEB) September 19, 2014 Are you ... because of problems with seasonal allergies or sinus congestion? ... much better alternative. , She conceived of Nose ... having a runny nose in public. Since it prevents ... promotes more sanitary conditions, particularly when cooking or working ...
(Date:9/19/2014)... Unbound , an international humanitarian organization based in ... Philippines being affected by both a tropical storm and an ... the nearest public schools while others moved to higher ground ... to portions of the northern Philippines. , The storm ... more than 10 feet of water. , “It is ...
(Date:9/19/2014)... September 19, 2014 BearCom, a ... today detailed the key role played by instant, ... in the healthcare industry. , “In healthcare, ... care – and in emergency situations, can save ... life and death,” said Hugh Johnston, Product & ...
(Date:9/19/2014)... News) -- As kids transition from elementary to middle ... to a recent study. But the researchers ... that verbal and physical bullying declines as students get ... prevention strategies must address all types of bullying as ... the researchers said. The study was published recently in ...
Breaking Medicine News(10 mins):Health News:PCMA: New OIG Report Cites Drug Manufacturer“Copay Coupon” Use in Medicare Part D 2Health News:Nasal Drip Eliminator Invented by InventHelp Client (LCC-218) 2Health News:Double Threat in Philippines Displaces Thousands of Unbound Families 2Health News:BearCom Releases Guidelines on Using Two-Way Radios to Improve Communications and Enhance Patient Service in Healthcare 2Health News:BearCom Releases Guidelines on Using Two-Way Radios to Improve Communications and Enhance Patient Service in Healthcare 3Health News:BearCom Releases Guidelines on Using Two-Way Radios to Improve Communications and Enhance Patient Service in Healthcare 4Health News: Cyberbullying Seems to Ramp Up in Middle School 2
... to a recent finding, Americans whose diet was Mediterranean, ... fish and alcohol, and little dairy and meat, certainly ... aged.// These findings have been published in the April ... in the field of diet , Alzheimer’s development is ...
... Florida study has found that elderly people turn to God ... were not spiritually inclined during their earlier days.// The study, ... says that talking about God may actually increase the fear ... healthy older adults and 19 hospice patients in North Central ...
... United Nations are alarming that the actual number of ... (ranges are from 24,000 to 150,000).// ,Of ... quarter ending June 2004 was injecting drug use (73.72 ... cent), men who have sex with men (4.0 per ...
... feel that your child is getting too little calcium, think ... of supplements and calcium-fortified foods that builds stronger bones.// ... healthy children has little benefit for bone health," said lead ... be pursued as a public health policy for healthy children, ...
... are wrong. In fact, they are at increased risk of ... from Britain's Mental Health Foundation (MHF) studied over 1,000 people ... feelings of stress, anxiety and depression, reported the online edition ... know that they are putting themselves at increased risk of ...
... travelers who are prone to travel-related blood clots during ... a pair of elastic support hose before boarding. // ... stockings can prevent deep vein thrombosis. Sometimes called “traveler’s ... coagulates into small clots inside a blood vessel. ...
Cached Medicine News:Health News:Calcium Supplements May Not Be Of Much Use For Healthy Kids 2Health News:Travel-Related Blood Clots Can Be Reduced By Using Flight Stockings 2
Ernest nucleus cracker extra delicate cross-action serrated paddle shaped jaws for cracking the nucleus through a 2.5 mm incision....
Epilation forceps straight ends size 3.5"....
Removal Forceps, very fine pointed tips, with textured jaws, ideal for grasping wet sutures....
Forceps, extra delicate, straight....
Medicine Products: